ITGRNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Integer Holdings Corp
Financials through Q2 FY2026, quarter ended Jul 3, 2026Last filing: 10-Q on Aug 4, 2026
$126.75+0.05 (+0.04%)
Close on Oct 19, 2026
- Market cap
- $4.33B
- P/E (TTM)
- 34.6
- Dividend yield
- –
Integer Holdings Corp revenue by segment
By business segment
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medical | – | – | – | – | – | – | – | – | $427.38M | $407.21M | $404.06M | $395.90M | – | – |
| Non-Medical | – | – | – | – | – | – | – | – | $8.82M | $7.59M | $9.09M | $8.79M | – | – |
| Operating income | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medical | – | – | – | – | – | – | – | – | $81.41M | $72.35M | $72.52M | $73.69M | – |
| Non-Medical | – | – | – | – | – | – | – | – | $508.00K | $299.00K | -$217.00K | -$905.00K | – |
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cardio & Vascular | $280.31M | $261.73M | $284.21M | $277.15M | $286.86M | $258.87M | $255.30M | $241.01M | $231.42M | $221.85M | $222.64M | $214.00M | 60.4% | -2.3% |
| Cardiac Rhythm Management & Neuromodulation | $173.71M | $168.26M | $167.30M | $169.16M | $172.00M | $160.35M | $170.52M | $165.09M | $168.06M | $156.93M | $153.25M | $160.12M | 37.4% | +1.0% |
| Other Markets | $10.09M | $9.58M | $20.55M | $21.39M | $17.64M | $18.18M | $23.68M | $25.31M | $28.41M | $29.01M | – | – | 2.2% | -42.8% |
| Advanced Surgical, Orthopedics & Portable Medical | – | – | – | – | – | – | – | $25.31M | – | – | – | $22.68M | – | – |
By region
From the segment and revenue-disaggregation notes of Integer's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.